Insiders · Profile

Giacobello Scott M.

CHIEF FINANCIAL OFFICER at Whitehawk Therapeutics. Filing since 3 Mar 2025. CIK 0001754154

Company
Date
Role
Action
Shares
Amount
Of holding
16 Apr 2026
CHIEF FINANCIAL OFFICER
Sold at will
141,600
$584.81K
32.4%
15 Apr 2026
CHIEF FINANCIAL OFFICER
Sold at will
77,000
$297.22K
15.0%
2 Mar 2026
CHIEF FINANCIAL OFFICER
Sold at will
2,594
$8.59K
8.5%
3 Mar 2025
CHIEF FINANCIAL OFFICER
Sold at will
2,806
$6.59K
10.5%
4 decisions on file.